{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:32:43Z","timestamp":1793363563933,"version":"4.5.0"},"reference-count":42,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["NHMRC Career Development Fellowship (APP #1148372)"],"award-info":[{"award-number":["NHMRC Career Development Fellowship (APP #1148372)"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2021,4,29]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We aimed to evaluate the effectiveness of contact investigation in comparison with passive case detection alone, and estimate the yield of co-prevalent and incident tuberculosis (TB) and latent TB infection (LTBI) among contacts of patients with TB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was undertaken of studies published between 1 January 2011 and 1 October 2019 in the English language. The proportion of contacts diagnosed with co-prevalent TB, incident TB and\/or LTBI was estimated. Evaluation of the effectiveness of contact investigation included randomised trials, while the yield of contact investigation (co-prevalent\/incident TB and LTBI) was assessed in nonrandomised studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data were extracted from 244 studies, of which 187 studies measured the proportion of contacts diagnosed with TB disease and 135 studies measured LTBI prevalence. Individual randomised trials demonstrated that contact investigation increased TB case notification (relative risk 2.5, 95% CI 2.0\u20133.2) and TB case detection (OR 1.34, 95% CI 0.43\u20134.24) and decreased mortality (relative risk 0.6, 95% CI 0.4\u20130.8) and population TB prevalence (risk ratio 0.82, 95% CI 0.64\u20131.04). The overall pooled prevalence of TB was 3.6% (95% CI 3.3\u20134.0%; I<jats:sup>2<\/jats:sup>=98.9%, 181 studies). The pooled prevalence of microbiologically confirmed TB was 3.2% (95% CI 2.6\u20133.7%; I<jats:sup>2<\/jats:sup>=99.5%, 106 studies). The pooled incidence of TB was highest in the first year after exposure to index patients (2.0%, 95% CI 1.1\u20133.3%; I<jats:sup>2<\/jats:sup>=96.2%, 14 studies) and substantially lower 5\u2005years after exposure to index patients (0.5%, 95% CI 0.3\u20130.9%; one study). The pooled prevalence of LTBI among contacts was 42.4% (95% CI 38.5\u201346.4%; I<jats:sup>2<\/jats:sup>=99.8%, 135 studies).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This systematic review and meta-analysis found that contact investigation was effective in high-burden settings. The higher pooled prevalence estimates of microbiologically confirmed TB compared with previous reviews suggests newer rapid molecular diagnostics contribute to increased case detection.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.00266-2021","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T16:10:15Z","timestamp":1621527015000},"page":"2100266","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":86,"title":["The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis"],"prefix":"10.1183","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-3915","authenticated-orcid":false,"given":"Kavindhran","family":"Velen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi Vijay","family":"Shingde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg James","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"2024102102290993000_58.6.2100266.1","unstructured":"World Health Organization . Global Tuberculosis Report 2019. Geneva, WHO, 2019."},{"key":"2024102102290993000_58.6.2100266.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30024-8"},{"key":"2024102102290993000_58.6.2100266.3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijmyco.2016.09.023","article-title":"Passive case finding for tuberculosis is not enough","volume":"5","author":"Ho","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"2024102102290993000_58.6.2100266.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.8.991"},{"key":"2024102102290993000_58.6.2100266.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700209"},{"key":"2024102102290993000_58.6.2100266.6","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.16.0576"},{"key":"2024102102290993000_58.6.2100266.7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/ciz235","article-title":"Feasibility of identifying household contacts of rifampin- and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease","volume":"70","author":"Gupta","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024102102290993000_58.6.2100266.8","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2214-109X(20)30133-9","article-title":"Scaling up tuberculosis preventive therapy for contacts in high transmission settings","volume":"8","author":"Majumdar","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2024102102290993000_58.6.2100266.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61131-9"},{"key":"2024102102290993000_58.6.2100266.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"2024102102290993000_58.6.2100266.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2024102102290993000_58.6.2100266.12","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2024102102290993000_58.6.2100266.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2024102102290993000_58.6.2100266.14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5588\/ijtld.14.0512","article-title":"Tuberculosis contact investigation in low and middle income countries: standardized definitions and indicators","volume":"19","author":"Fair","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102102290993000_58.6.2100266.15","unstructured":"World Bank . World Bank Country Classification. 2020. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups Date last accessed: 26 October 2020."},{"key":"2024102102290993000_58.6.2100266.16","unstructured":"Wells GA , Shea B , O'Connell D , et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2010. www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp Date last accessed: 22 May 2021."},{"key":"2024102102290993000_58.6.2100266.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2024102102290993000_58.6.2100266.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00377-8"},{"key":"2024102102290993000_58.6.2100266.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2024102102290993000_58.6.2100266.20","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00112-2019"},{"key":"2024102102290993000_58.6.2100266.21","doi-asserted-by":"crossref","first-page":"e1002796","DOI":"10.1371\/journal.pmed.1002796","article-title":"Contact tracing versus facility-based screening for active TB case finding in rural South Africa: a pragmatic cluster-randomized trial (Kharitode TB)","volume":"16","author":"Hanrahan","year":"2019","journal-title":"PLoS Med"},{"key":"2024102102290993000_58.6.2100266.22","doi-asserted-by":"crossref","first-page":"e0192089","DOI":"10.1371\/journal.pone.0192089","article-title":"Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa","volume":"13","author":"Page-Shipp","year":"2018","journal-title":"PLoS One"},{"key":"2024102102290993000_58.6.2100266.23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/cid\/ciz436","article-title":"Improving TPT uptake: a cluster-randomized trial of symptom-based versus tuberculin skin test-based screening of household tuberculosis contacts less than 5 years of age","volume":"70","author":"Salazar-Austin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024102102290993000_58.6.2100266.24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00070812"},{"key":"2024102102290993000_58.6.2100266.25","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(18)30458-3","article-title":"Effect of Xpert MTB\/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis","volume":"7","author":"Di Tanna","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024102102290993000_58.6.2100266.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31644-1"},{"key":"2024102102290993000_58.6.2100266.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01044-2017"},{"key":"2024102102290993000_58.6.2100266.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033945"},{"key":"2024102102290993000_58.6.2100266.29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s13063-018-3070-0","article-title":"Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)","volume":"19","author":"Seddon","year":"2018","journal-title":"Trials"},{"key":"2024102102290993000_58.6.2100266.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15332-9"},{"key":"2024102102290993000_58.6.2100266.31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00214014"},{"key":"2024102102290993000_58.6.2100266.32","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.Supplement_1.S66"},{"key":"2024102102290993000_58.6.2100266.33","unstructured":"World Health Organization . Latent Tuberculosis Infection. Updated and Consolidated Guidelines for Programmatic Management. Geneva, WHO, 2018."},{"key":"2024102102290993000_58.6.2100266.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043307"},{"key":"2024102102290993000_58.6.2100266.35","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70071-9"},{"key":"2024102102290993000_58.6.2100266.36","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30691-6"},{"key":"2024102102290993000_58.6.2100266.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001843"},{"key":"2024102102290993000_58.6.2100266.38","unstructured":"World Health Organization . WHO Guidelines on Tuberculosis Infection Prevention and Control, 2019 Update. Geneva, WHO, 2019."},{"key":"2024102102290993000_58.6.2100266.39","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00034-13"},{"key":"2024102102290993000_58.6.2100266.40","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2468-2667(20)30261-9","article-title":"Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial","volume":"6","author":"Oxlade","year":"2021","journal-title":"Lancet Public Health"},{"key":"2024102102290993000_58.6.2100266.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30216-X"},{"key":"2024102102290993000_58.6.2100266.42","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/s12879-018-3586-7","article-title":"Improving detection of tuberculosis among household contacts of index tuberculosis patients by an integrated approach in Myanmar: a cross-sectional study","volume":"18","author":"Htet","year":"2018","journal-title":"BMC Infect Dis"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00266-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:44:45Z","timestamp":1740375885000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00266-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,12,9]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1183\/13993003.00266-2021"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00266-2021","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}